Lamivudine & Zidovudine Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Lamivudine 150 mg + Zidovudine 300 mg
Reference Brands: Combivir®(US/ EU)
Category: Anti Viral
Lamivudine & Zidovudine Tablets (150 mg/300 mg) offer a fixed-dose antiretroviral for HIV treatment. Available through PharmaB2B from certified manufacturers, it's ideal for tenders, NGOs, and hospital procurement. Ensure compliant, bulk sourcing from WHO-GMP and USFDA-approved suppliers to support reliable HIV therapy access globally.
Product Description:
Lamivudine & Zidovudine Tablets are a fixed-dose combination of two key NRTIs used in the management of HIV-1 infection. Each tablet contains Lamivudine 150 mg and Zidovudine 300 mg, offering dual-action antiviral activity in a convenient dosing format. Available under brands like Combivir®, this formulation is widely used in global HIV treatment protocols. Through PharmaB2B platforms, healthcare providers and procurement agencies can access bulk supplies from WHO-GMP and USFDA-approved manufacturers. Ideal for tenders, NGOs, and institutional buyers, this ARV combo supports consistent, cost-effective treatment. Connect with trusted suppliers to ensure high-quality antiretrovirals and uninterrupted patient care.
Lamivudine & Zidovudine — third party manufacturing & bulk supply
Lamivudine & Zidovudine is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Lamivudine & Zidovudine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Lamivudine & Zidovudine →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Lamivudine and zidovudine are used together to treat HIV-1 infection. This fixed-dose combination helps reduce viral load, improve immune function, and slow the progression of HIV as part of combination antiretroviral therapy.
It is made from two nucleoside reverse transcriptase inhibitors (NRTIs): lamivudine, a synthetic cytidine analogue, and zidovudine, a thymidine analogue. Together, they block viral replication by inhibiting the HIV reverse transcriptase enzyme.
The most common trade name is Combivir.
Combivir is manufactured by GlaxoSmithKline (GSK) and ViiV Healthcare, with additional production by global generic pharmaceutical companies.
The generic name is lamivudine and zidovudine.
The primary brand name is Combivir.
It is manufactured in approved facilities in the UK, USA, Europe, and India, depending on the manufacturer and regulatory approvals for each region.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
